reference/18181226

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18181226

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1932-6203
issueIdentifier	6
pageRange	e0128970-
publicationName	PLOS ONE
startingPage	e0128970
bibliographicCitation	Yang L, Tang C, Xu B, Wang W, Li J, Li X, Qin H, Gao H, He K, Song S, Liu X. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer. PLoS ONE. 2015 Jun 05;10(6):e0128970. doi: 10.1371/journal.pone.0128970.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13d80a3fbb0b14bf6eb3a315d0a5d268 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0e9803ee13ff7756858ea4399d6ea35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_059d9cdcf0fb32b3e1981d899800d3b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_188430396a661c2bfda4968bed36b2d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0deab68bca4f64d3d3f8c66cdd00d1cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d82f3601aa6b65ee6687097216b7194 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2670f42c2b172f2d8821bf8a4673ecef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1703f55034b1aeb933efeb41e27f639c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e26555e6a097d73af755edfc1b37017d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36d9c76a0f820d13a53bdd0812cddd6b
date	2015-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4457791 https://doi.org/10.1371/journal.pone.0128970 https://pubmed.ncbi.nlm.nih.gov/26047516
isPartOf	https://portal.issn.org/resource/ISSN/1932-6203 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33103
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer
discusses	http://id.nlm.nih.gov/mesh/M0016238 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M0503963 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0457532
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000097 http://id.nlm.nih.gov/mesh/D008175Q000097 http://id.nlm.nih.gov/mesh/D012984 http://id.nlm.nih.gov/mesh/D010455Q000097 http://id.nlm.nih.gov/mesh/D014408Q000097 http://id.nlm.nih.gov/mesh/D066246Q000097
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D002289Q000175 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D066246Q000235 http://id.nlm.nih.gov/mesh/D047428Q000627 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D015870 http://id.nlm.nih.gov/mesh/D054316Q000097 http://id.nlm.nih.gov/mesh/D000465 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008175Q000175 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D019032 http://id.nlm.nih.gov/mesh/D014408Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Total number of triples: 67.